Macrophage Functions in Atherosclerosis
2014; Lippincott Williams & Wilkins; Volume: 115; Issue: 12 Linguagem: Inglês
10.1161/circresaha.114.305641
ISSN1524-4571
AutoresIris Zeller, Sanjay Srivastava,
Tópico(s)Immune cells in cancer
ResumoHomeCirculation ResearchVol. 115, No. 12Macrophage Functions in Atherosclerosis Free AccessResearch ArticlePDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessResearch ArticlePDF/EPUBMacrophage Functions in Atherosclerosis Iris Zeller and Sanjay Srivastava Iris ZellerIris Zeller From the Institute of Molecular Cardiology and Diabetes and Obesity Center, University of Louisville, KY 40202. and Sanjay SrivastavaSanjay Srivastava From the Institute of Molecular Cardiology and Diabetes and Obesity Center, University of Louisville, KY 40202. Originally published5 Dec 2014https://doi.org/10.1161/CIRCRESAHA.114.305641Circulation Research. 2014;115:e83–e85Atherosclerosis is a chronic inflammatory disease of the arterial wall instigated by the excessive accumulation of lipoproteins; monocyte recruitment and their differentiation into macrophages in the subendothelial space. Repeated failure of innate immune responses to clear subintimal low-density lipoprotein (LDL), results in the deposition of lipid-laden macrophages or foam cells. Foam cells secrete proinflammatory mediators that facilitate lipoprotein retention and maintain vascular inflammation.1 Advancement of lesion is characterized by the apoptosis of these macrophages in the lipid core. Macrophage apoptosis plays a dual role in atherosclerosis. In early fatty streaks lesions, efferocytosis removes apoptotic cells and prevents lesion development, whereas in the advanced lesions, efferocytosis is not efficient to clear the apoptotic debri, leading to the formation of necrotic core which further enhances inflammation and atherogenesis.2Accumulating indirect evidence suggests that the antiatherogenic role of high density lipoprotein (HDL) could at least in part, be due to its ability to stimulate cholesterol efflux from macrophages by ATP-binding cassette transporter A1 and G1 (ABCA1 and ABCG1). Complementing this notion, recent studies by Westerterp et al3 show that macrophage deficiency of ABCA1/G1 enhances lipid accumulation in macrophages, atherosclerosis and lesion inflammation. These authors observed that macrophage foam cells in spleen facilitate monocytosis which is inhibited by ABCA1/G1 and high levels of HDL. Studies by Ramirez et al4 demonstrate that activation of liver X receptor (LXR) augments the transcription of microRNA 144 (miR144) and inhibition of miR144 in macrophages upregulates ABCA1 expression and cholesterol efflux. In vivo, supplementation of mice with miR144 suppresses ABCA1 expression in the liver and reduces plasma HDL levels. Silencing of miR144 enhances ABCA1 expression and plasma HDL concentration. Activation of nuclear receptor farnesoid X receptor (FXR) also increases the expression of miR144 in the liver, which in turn downregulates ABCA1 protein and decreases plasma HDL.5 Conversely, silencing of miR144 in mice upregulates hepatic ABCA1 and increases plasma HDL levels. Together, these studies provide further evidence that ABCA1 is a critical regulator of cholesterol efflux and miR144 could be a potential therapeutic target for increasing the circulating levels of HDL.Although, it is well recognized that macrophages play a critical role in all stages of atherosclerosis, sources of lesional macrophages and mechanisms of accumulation of macrophages in atherosclerotic lesions have been a matter of debate. Monocytes are widely recognized as critical players in chronic inflammatory disease like atherosclerosis. At least two distinct monocyte subsets with differential migratory properties have been characterized in humans and mice.6 Murine Ly6Chigh monocytes express high levels of CCR2, are Inflammatory and functionally similar to CD16- CD14+ monocytes in humans. In hypercholesterolemic mice, macrophages in early lesions are predominantly derived from Ly6Chigh monocytes recruited in the intima.7,8 The Ly6Clow "patrolling" monocytes do not express CCR2 and are similar to CD14dim CD16+ "patrolling" monocytes in humans. The Ly6Clow monocytes patrol the vasculature and are recruited in atherosclerotic lesions less frequently. Orphan receptor Nur 77 has been suggested to be a critical regulator of differentiation and survival of Ly6Clow monocytes.9 Recent studies show that the absence of Nur 77 in hematopoietic cells enhances atherosclerosis in western diet-fed LDLR-KO mice.10 Deficiency of Nur 77 in monocytes and macrophages increased TLR4 signaling and polarization of macrophages toward proinflammatory M1 phenotype in NF-κB dependent manner. Nur 77 therefore could be a potential target for modulating inflammation in atherosclerotic plaque.Mitochondrial oxidation in lesional cells is well documented in experimental animals and humans.11,12 However, it is unclear whether mitochondrial oxidative stress is causally involved in the pathogenesis of atherosclerosis and if so, what are the underling mechanisms? Recently, Wang et al13 reported that mitochondria targeted expression of catalase in macrophages suppresses mitochondrial oxidative stress in lesional macrophages, decreases atherosclerosis and prevents the recruitment of Ly6Chigh cells in the lesions. Mechanistic studies showed that mitochondrial oxidative stress augments monocyte infiltration through the activation of IKKβ-RelA(NF-κB) which enhances the expression of monocyte chemotactic protein-1. Lingrel et al14 observed that myeloid cells specific deficiency of the zinc finger transcription factor, kruppel like factor 2 (KLF2), augments atherosclerosis and enhances the recruitment of neutrophils and macrophages to atherosclerotic lesions due to their increased adhesion to endothelial cells. This was accompanied by increased oxidative stress in the lesion. These recent findings complement earlier studies which showed that global hemizygous deficiency of KLF2 exacerbates atherosclerosis in hypercholesterolemic mice.15Rapamycin complex 1 (mTORC1) inhibitor, rapamycin, has also been suggested to reduce inflammation and prevent atherosclerosis.16 Recent studies by Ai et al17 show that ablation of Raptor gene in macrophages decreases mTOR activity, atherosclerosis, macrophage accumulation and chemokine gene expression in atherosclerotic lesions. In vitro studies showed that upon treatment of macrophages with minimally oxidized LDL, mTORC1 activity enhanced the induction of chemokines by increasing IL6 signaling. Driscoll et al18 reported that in mice, deficiency of transmembrane protease ADAM17 augments macrophage dependent efferocytosis which enhances anti-inflammatory response.Folco et al19 have probed the association between hypoxia, prevalent in atherosclerotic plaques, and inflammation. Their studies show that exposure of lipopolysaccharide-primed human macrophages to moderate level of hypoxia impedes the autophagic degradation resulting in increased intracellular accumulation of IL-1β, induction of NLRP3 and activation of inflammasome, and augmented caspase-1 activity. In human carotid artery lesions, IL-1β colocalized with macrophage rich regions that express activated caspase 1 and the markers of hypoxia - hypoxia-inducible factor 1α and hexokinase-2.Recent studies have also suggested that influenced by the microenvironment, lesional macrophages proliferate in atherosclerotic lesions.20 Sayin et al21 observed that deficiency of Zinc finger protein 148 (Zfp 148) enhances p53 activity and prevents atherosclerosis by blocking the proliferation of lesional macrophages.Although monocyte derived macrophages play a key role in atherosclerosis, vascular smooth muscle cells (SMC) can also migrate from tunica media to the intima, where they engulf lipoproteins to form foam cells.22 Using linear tracing experiments, Feil et al23 showed that in atherosclerosis, SMC can undergo clonal expansion and transdifferentiate into macrophage like cells. Authors claim that these SMC-derived macrophages are a major component of advanced lesions. Moreover, since these cells no longer express the markers of SMC such as α-smooth muscle actin, it is plausible that previous immunostaining studies underestimated the abundance of SMC-derived macrophages in atherosclerotic plaques.Stem progenitor cells (SPC) have been suggested to be another source of SMC and monocyte/macrophages in atherosclerotic lesion formation and progression.24–26 In atherosclerotic lesions, SPC can either be recruited from the bone marrow via blood circulation or from the vessel wall. Recent studies by Xiao et al25 show that matrix metalloproteinase 8 (MMP8) plays a pivotal role in SMC migration and recruitment to atherosclerotic plaque. Authors showed that deficiency of MMP8 in apoE-KO mice decreases the abundance of SPC in atherosclerotic lesions; apoE-KO/MMP8-KO mice transplanted with MMP8 deficient SMC displayed smaller lesions than ApoE-KO/MMP8-KO mice which received SMC from wild type mice; and deficiency of MMP8 in SPC diminished their ability to migrate through the endothelium or extracellular matrix; or into the arterial lesions.Together, recent work reinforces the idea that macrophages play a central role in all stages of atherosclerosis and targeted inhibition of lesional macrophage inflammation could be beneficial in protecting against atherosclerotic lesion formation.Recent Developments in Cardiovascular Research: The goal of "Recent Developments" is to provide a concise but comprehensive overview of new advances in cardiovascular research, which we hope will keep our readers abreast of recent scientific discoveries and facilitate discussion, interpretation, and integration of the findings. This will enable readers who are not experts in a particular field to grasp the significance and effect of work performed in other fields. It is our hope and expectation that these "Recent Development" articles will help readers to gain a broader awareness and a deeper understanding of the status of research across the vast landscape of cardiovascular research—The Editors.AcknowledgmentsThis work was supported in parts by NIH grants HL95593, ES17260, and GM 103492.FootnotesCorrespondence to Sanjay Srivastava, PhD, FAHA, Department of Medicine, Division of Cardiovascular Medicine, 204 F, Delia Baxter Building, 580 S Preston St, University of Louisville, Louisville, KY 40202. Email [email protected]References1. Libby P. Inflammation in atherosclerosis.Nature. 2002; 420:868–874. doi: 10.1038/nature01323.CrossrefMedlineGoogle Scholar2. Gautier EL, Huby T, Witztum JL, Ouzilleau B, Miller ER, Saint-Charles F, Aucouturier P, Chapman MJ, Lesnik P. Macrophage apoptosis exerts divergent effects on atherogenesis as a function of lesion stage.Circulation. 2009; 119:1795–1804. doi: 10.1161/CIRCULATIONAHA.108.806158.LinkGoogle Scholar3. Westerterp M, Murphy AJ, Wang M, Pagler TA, Vengrenyuk Y, Kappus MS, Gorman DJ, Nagareddy PR, Zhu X, Abramowicz S, Parks JS, Welch C, Fisher EA, Wang N, Yvan-Charvet L, Tall AR. Deficiency of atp-binding cassette transporters a1 and g1 in macrophages increases inflammation and accelerates atherosclerosis in mice.Circ Res. 2013; 112:1456–1465.LinkGoogle Scholar4. Ramirez CM, Rotllan N, Vlassov AV, Davalos A, Li M, Goedeke L, Aranda JF, Cirera-Salinas D, Araldi E, Salerno A, Wanschel A, Zavadil J, Castrillo A, Kim J, Suarez Y, Fernandez-Hernando C. Control of cholesterol metabolism and plasma high-density lipoprotein levels by microrna-144.Circ Res. 2013; 112:1592–1601.LinkGoogle Scholar5. de Aguiar Vallim TQ, Tarling EJ, Kim T, Civelek M, Baldán Á, Esau C, Edwards PA. MicroRNA-144 regulates hepatic ATP binding cassette transporter A1 and plasma high-density lipoprotein after activation of the nuclear receptor farnesoid X receptor.Circ Res. 2013; 112:1602–1612. doi: 10.1161/CIRCRESAHA.112.300648.LinkGoogle Scholar6. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties.Immunity. 2003; 19:71–82.CrossrefMedlineGoogle Scholar7. Swirski FK, Libby P, Aikawa E, Alcaide P, Luscinskas FW, Weissleder R, Pittet MJ. Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata.J Clin Invest. 2007; 117:195–205. doi: 10.1172/JCI29950.CrossrefMedlineGoogle Scholar8. Randolph GJ. Mechanisms that regulate macrophage burden in atherosclerosis.Circ Res. 2014; 114:1757–1771. doi: 10.1161/CIRCRESAHA.114.301174.LinkGoogle Scholar9. Hanna RN, Carlin LM, Hubbeling HG, Nackiewicz D, Green AM, Punt JA, Geissmann F, Hedrick CC. The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C- monocytes.Nat Immunol. 2011; 12:778–785. doi: 10.1038/ni.2063.CrossrefMedlineGoogle Scholar10. Hanna RN, Shaked I, Hubbeling HG, Punt JA, Wu R, Herrley E, Zaugg C, Pei H, Geissmann F, Ley K, Hedrick CC. NR4A1 (Nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosis.Circ Res. 2012; 110:416–427. doi: 10.1161/CIRCRESAHA.111.253377.LinkGoogle Scholar11. Madamanchi NR, Runge MS. Mitochondrial dysfunction in atherosclerosis.Circ Res. 2007; 100:460–473. doi: 10.1161/01.RES.0000258450.44413.96.LinkGoogle Scholar12. Madamanchi NR, Zhou RH, Vendrov AE, Niu XL, Runge MS. Does oxidative DNA damage cause atherosclerosis and metabolic syndrome?: new insights into which came first: the chicken or the egg.Circ Res. 2010; 107:940–942. doi: 10.1161/CIRCRESAHA.110.230904.LinkGoogle Scholar13. Wang Y, Wang GZ, Rabinovitch PS, Tabas I. Macrophage mitochondrial oxidative stress promotes atherosclerosis and nuclear factor-κB-mediated inflammation in macrophages.Circ Res. 2014; 114:421–433. doi: 10.1161/CIRCRESAHA.114.302153.LinkGoogle Scholar14. Lingrel JB, Pilcher-Roberts R, Basford JE, Manoharan P, Neumann J, Konaniah ES, Srinivasan R, Bogdanov VY, Hui DY. Myeloid-specific Krüppel-like factor 2 inactivation increases macrophage and neutrophil adhesion and promotes atherosclerosis.Circ Res. 2012; 110:1294–1302. doi: 10.1161/CIRCRESAHA.112.267310.LinkGoogle Scholar15. Atkins GB, Wang Y, Mahabeleshwar GH, Shi H, Gao H, Kawanami D, Natesan V, Lin Z, Simon DI, Jain MK. Hemizygous deficiency of Krüppel-like factor 2 augments experimental atherosclerosis.Circ Res. 2008; 103:690–693. doi: 10.1161/CIRCRESAHA.108.184663.LinkGoogle Scholar16. Castro C, Campistol JM, Sancho D, Sánchez-Madrid F, Casals E, Andrés V. Rapamycin attenuates atherosclerosis induced by dietary cholesterol in apolipoprotein-deficient mice through a p27 Kip1 -independent pathway.Atherosclerosis. 2004; 172:31–38.CrossrefMedlineGoogle Scholar17. Ai D, Jiang H, Westerterp M, Murphy AJ, Wang M, Ganda A, Abramowicz S, Welch C, Almazan F, Zhu Y, Miller YI, Tall AR. Disruption of mammalian target of rapamycin complex 1 in macrophages decreases chemokine gene expression and atherosclerosis.Circ Res. 2014; 114:1576–1584. doi: 10.1161/CIRCRESAHA.114.302313.LinkGoogle Scholar18. Driscoll WS, Vaisar T, Tang J, Wilson CL, Raines EW. Macrophage ADAM17 deficiency augments CD36-dependent apoptotic cell uptake and the linked anti-inflammatory phenotype.Circ Res. 2013; 113:52–61. doi: 10.1161/CIRCRESAHA.112.300683.LinkGoogle Scholar19. Folco EJ, Sukhova GK, Quillard T, Libby P. Moderate hypoxia potentiates interleukin-1β production in activated human macrophages.Circ Res. 2014; 115:875–883. doi: 10.1161/CIRCRESAHA.115.304437.LinkGoogle Scholar20. Robbins CS, Hilgendorf I, Weber GF, Theurl I, Iwamoto Y, Figueiredo JL, Gorbatov R, Sukhova GK, Gerhardt LM, Smyth D, Zavitz CC, Shikatani EA, Parsons M, van Rooijen N, Lin HY, Husain M, Libby P, Nahrendorf M, Weissleder R, Swirski FK. Local proliferation dominates lesional macrophage accumulation in atherosclerosis.Nat Med. 2013; 19:1166–1172.CrossrefMedlineGoogle Scholar21. Sayin VI, Khan OM, Pehlivanoglu LE, Staffas A, Ibrahim MX, Asplund A, Agren P, Nilton A, Bergström G, Bergo MO, Borén J, Lindahl P. Loss of One Copy of Zfp148 Reduces Lesional Macrophage Proliferation and Atherosclerosis in Mice by Activating p53.Circ Res. 2014; 115:781–789. doi: 10.1161/CIRCRESAHA.115.304992.LinkGoogle Scholar22. Swirski FK, Nahrendorf M. Do vascular smooth muscle cells differentiate to macrophages in atherosclerotic lesions?Circ Res. 2014; 115:605–606. doi: 10.1161/CIRCRESAHA.114.304925.LinkGoogle Scholar23. Feil S, Fehrenbacher B, Lukowski R, Essmann F, Schulze-Osthoff K, Schaller M, Feil R. Transdifferentiation of vascular smooth muscle cells to macrophage-like cells during atherogenesis.Circ Res. 2014; 115:662–667. doi: 10.1161/CIRCRESAHA.115.304634.LinkGoogle Scholar24. Hu Y, Davison F, Ludewig B, Erdel M, Mayr M, Url M, Dietrich H, Xu Q. Smooth muscle cells in transplant atherosclerotic lesions are originated from recipients, but not bone marrow progenitor cells.Circulation. 2002; 106:1834–1839.LinkGoogle Scholar25. Xiao Q, Zhang F, Lin L, Fang C, Wen G, Tsai TN, Pu X, Sims D, Zhang Z, Yin X, Thomaszewski B, Schmidt B, Mayr M, Suzuki K, Xu Q, Ye S. Functional role of matrix metalloproteinase-8 in stem/progenitor cell migration and their recruitment into atherosclerotic lesions.Circ Res. 2013; 112:35–47.LinkGoogle Scholar26. Febbraio M, Guy E, Silverstein RL. Stem cell transplantation reveals that absence of macrophage CD36 is protective against atherosclerosis.Arterioscler Thromb Vasc Biol. 2004; 24:2333–2338. doi: 10.1161/01.ATV.0000148007.06370.68.LinkGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited ByCynn E, Li D, O'Reilly M, Wang Y, Bashore A, Jha A, Foulkes A, Zhang H, Winter H, Maegdefessel L, Yan H, Li M, Ross L, Xue C and Reilly M (2022) Human Macrophage Long Intergenic Noncoding RNA, SIMALR, Suppresses Inflammatory Macrophage Apoptosis via NTN1 (Netrin-1), Arteriosclerosis, Thrombosis, and Vascular Biology, 43:2, (286-299), Online publication date: 1-Feb-2023. Tang Q, Yi Y, Chen Y, Zhuang Z, Wang F, Zhang L, Wei S, Zhang Y, Wang Y, Liu L, Liu Q and Jiang C (2022) A green and highly efficient method to deliver hydrophilic polyphenols of Salvia miltiorrhiza and Carthamus tinctorius for enhanced anti-atherosclerotic effect via metal-phenolic network, Colloids and Surfaces B: Biointerfaces, 10.1016/j.colsurfb.2022.112511, 215, (112511), Online publication date: 1-Jul-2022. Li Y, Che J, Chang L, Guo M, Bao X, Mu D, Sun X, Zhang X, Lu W and Xie J (2021) CD47‐ and Integrin α 4/ β 1‐Comodified‐Macrophage‐Membrane‐Coated Nanoparticles Enable Delivery of Colchicine to Atherosclerotic Plaque , Advanced Healthcare Materials, 10.1002/adhm.202101788, 11:4, (2101788), Online publication date: 1-Feb-2022. Li R, Zhang C, Xie F, Zhou X, Hu X, Shi J, Du X, Lin Z and Dong N (2022) Protein Phosphatase 2A Deficiency in Macrophages Increases Foam Cell Formation and Accelerates Atherosclerotic Lesion Development, Frontiers in Cardiovascular Medicine, 10.3389/fcvm.2021.745009, 8 Hu M, Jana S, Kilic T, Wang F, Shen M, Winkelaar G, Oudit G, Rayner K, Zhang D and Kassiri Z (2021) Loss of TIMP4 (Tissue Inhibitor of Metalloproteinase 4) Promotes Atherosclerotic Plaque Deposition in the Abdominal Aorta Despite Suppressed Plasma Cholesterol Levels, Arteriosclerosis, Thrombosis, and Vascular Biology, 41:6, (1874-1889), Online publication date: 1-Jun-2021. Tian Y, Ling X, Chen D, Zhang X and Qiu C (2020) Interleukin‐36 receptor antagonist attenuates atherosclerosis development by inhibiting NLRP3 inflammasome, Journal of Cellular Physiology, 10.1002/jcp.29813, 235:12, (9992-9996), Online publication date: 1-Dec-2020. Wang Y, Ji N, Gong X, Ni S, Xu L and Zhang H (2020) Thioredoxin-1 attenuates atherosclerosis development through inhibiting NLRP3 inflammasome, Endocrine, 10.1007/s12020-020-02389-z, 70:1, (65-70), Online publication date: 1-Oct-2020. Opazo-Ríos L, Mas S, Marín-Royo G, Mezzano S, Gómez-Guerrero C, Moreno J and Egido J (2020) Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities, International Journal of Molecular Sciences, 10.3390/ijms21072632, 21:7, (2632) Tong H, Zhang X, Tan L, Jin R, Huang S and Li X (2020) Multitarget and promising role of dihydromyricetin in the treatment of metabolic diseases, European Journal of Pharmacology, 10.1016/j.ejphar.2019.172888, 870, (172888), Online publication date: 1-Mar-2020. Luo J, Wang X, Jiang X, Liu C, Li Y, Han X, Zuo X, Li Y, Li N, Xu Y and Si S (2019) Rutaecarpine derivative R3 attenuates atherosclerosis via inhibiting NLRP3 inflammasome‐related inflammation and modulating cholesterol transport, The FASEB Journal, 10.1096/fj.201900903RRR, 34:1, (1398-1411), Online publication date: 1-Jan-2020. Alfarisi H, Mohamed Z and Ibrahim M (2020) Basic pathogenic mechanisms of atherosclerosis, Egyptian Journal of Basic and Applied Sciences, 10.1080/2314808X.2020.1769913, 7:1, (116-125), Online publication date: 1-Jan-2020. Zhang H, Gong X, Ni S, Wang Y, Zhu L and Ji N (2019) C1q/TNF-related protein-9 attenuates atherosclerosis through AMPK-NLRP3 inflammasome singling pathway, International Immunopharmacology, 10.1016/j.intimp.2019.105934, 77, (105934), Online publication date: 1-Dec-2019. Zhu H, Wang Z, Dong Z, Wang C, Cao Q, Fan F, Zhao J, Liu X, Yuan M, Sun X, Peng X, Zou Y, Zhou J, Ge J, Zhou X and Zhang Y (2019) Aldehyde dehydrogenase 2 deficiency promotes atherosclerotic plaque instability through accelerating mitochondrial ROS-mediated vascular smooth muscle cell senescence, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 10.1016/j.bbadis.2018.09.033, 1865:7, (1782-1792), Online publication date: 1-Jul-2019. Zhang L, Lu L, Zhong X, Yue Y, Hong Y, Li Y and Li Y (2019) Metformin reduced NLRP3 inflammasome activity in Ox-LDL stimulated macrophages through adenosine monophosphate activated protein kinase and protein phosphatase 2A, European Journal of Pharmacology, 10.1016/j.ejphar.2019.03.006, 852, (99-106), Online publication date: 1-Jun-2019. Tan L, Liu L, Jiang Z and Hao X (2019) Inhibition of microRNA-17-5p reduces the inflammation and lipid accumulation, and up-regulates ATP-binding cassette transporterA1 in atherosclerosis, Journal of Pharmacological Sciences, 10.1016/j.jphs.2018.11.012, 139:4, (280-288), Online publication date: 1-Apr-2019. Wang C, Petriello M, Zhu B and Hennig B (2019) PCB 126 induces monocyte/macrophage polarization and inflammation through AhR and NF-κB pathways, Toxicology and Applied Pharmacology, 10.1016/j.taap.2019.02.006, 367, (71-81), Online publication date: 1-Mar-2019. Trzepizur W, Cortese R and Gozal D (2018) Murine models of sleep apnea: functional implications of altered macrophage polarity and epigenetic modifications in adipose and vascular tissues, Metabolism, 10.1016/j.metabol.2017.11.008, 84, (44-55), Online publication date: 1-Jul-2018. Tang K, Wang F, Zeng Y, Chen X and Xu X (2018) Salusin-α attenuates hepatic steatosis and atherosclerosis in high fat diet-fed low density lipoprotein receptor deficient mice, European Journal of Pharmacology, 10.1016/j.ejphar.2018.04.026, 830, (76-86), Online publication date: 1-Jul-2018. Cui X, Luan J, Dong K, Chen S, Wang Y, Watford W and Chen S (2018) Response by Cui et al to Letter Regarding Article, "RGC-32 (Response Gene to Complement 32) Deficiency Protects Endothelial Cells From Inflammation and Attenuates Atherosclerosis", Arteriosclerosis, Thrombosis, and Vascular Biology, 38:6, (e97-e98), Online publication date: 1-Jun-2018. Zhang M, Zhao G, Yao F, Xia X, Gong D, Zhao Z, Chen L, Zheng X, Tang X and Tang C (2018) AIBP reduces atherosclerosis by promoting reverse cholesterol transport and ameliorating inflammation in apoE −/− mice, Atherosclerosis, 10.1016/j.atherosclerosis.2018.03.010, 273, (122-130), Online publication date: 1-Jun-2018. Guo M, Xiao J, Sheng X, Zhang X, Tie Y, Wang L, Zhao L and Ji X (2018) Ginsenoside Rg3 Mitigates Atherosclerosis Progression in Diabetic apoE–/– Mice by Skewing Macrophages to the M2 Phenotype, Frontiers in Pharmacology, 10.3389/fphar.2018.00464, 9 Wu C, He S, Liu J, Wang B, Lin J, Duan Y, Gao X and Li D (2018) Type 1 innate lymphoid cell aggravation of atherosclerosis is mediated through TLR4, Scandinavian Journal of Immunology, 10.1111/sji.12661, 87:5, (e12661), Online publication date: 1-May-2018. Lu H, Zong G, Zhou S, Jiang Y, Chen R, Su Z and Wu Y (2017) Angiotensin II-C-C chemokine receptor2/5 axis-dependent monocyte/macrophage recruitment contributes to progression of experimental autoimmune myocarditis, Microbiology and Immunology, 10.1111/1348-0421.12548, 61:12, (539-546), Online publication date: 1-Dec-2017. Oehler B, Kistner K, Martin C, Schiller J, Mayer R, Mohammadi M, Sauer R, Filipovic M, Nieto F, Kloka J, Pflücke D, Hill K, Schaefer M, Malcangio M, Reeh P, Brack A, Blum R and Rittner H (2017) Inflammatory pain control by blocking oxidized phospholipid-mediated TRP channel activation, Scientific Reports, 10.1038/s41598-017-05348-3, 7:1, Online publication date: 1-Dec-2017. Zhang H, Xue C, Wang Y, Shi J, Zhang X, Li W, Nunez S, Foulkes A, Lin J, Hinkle C, Yang W, Morrisey E, Rader D, Li M and Reilly M (2017) Deep RNA Sequencing Uncovers a Repertoire of Human Macrophage Long Intergenic Noncoding RNAs Modulated by Macrophage Activation and Associated With Cardiometabolic Diseases, Journal of the American Heart Association, 6:11, Online publication date: 1-Nov-2017. Liu T, Zeng Y, Tang K, Chen X, Zhang W and Xu X (2017) Dihydromyricetin ameliorates atherosclerosis in LDL receptor deficient mice, Atherosclerosis, 10.1016/j.atherosclerosis.2017.05.003, 262, (39-50), Online publication date: 1-Jul-2017. Lin X, Hu H, Liu Y, Hu X, Fan X, Zou W, Pan Y, Zhou W, Peng M and Gu C (2017)(2017) Allicin induces the upregulation of ABCA1 expression via PPARγ/LXRα signaling in THP-1 macrophage-derived foam cells, International Journal of Molecular Medicine, 10.3892/ijmm.2017.2949, 39:6, (1452-1460), Online publication date: 1-Jun-2017. Cortese R, Gileles-Hillel A, Khalyfa A, Almendros I, Akbarpour M, Khalyfa A, Qiao Z, Garcia T, Andrade J and Gozal D (2017) Aorta macrophage inflammatory and epigenetic changes in a murine model of obstructive sleep apnea: Potential role of CD36, Scientific Reports, 10.1038/srep43648, 7:1, Online publication date: 2-May-2017. Cao J, Ye B, Lin L, Tian L, Yang H, Wang C, Huang W and Huang Z (2017) Curcumin Alleviates oxLDL Induced MMP-9 and EMMPRIN Expression through the Inhibition of NF-κB and MAPK Pathways in Macrophages, Frontiers in Pharmacology, 10.3389/fphar.2017.00062, 8 Boyle M (2017) Immunopathology of the Cardiovascular System Immunopathology in Toxicology and Drug Development, 10.1007/978-3-319-47385-7_9, (455-477), . Jansen M, Hollander M, van Royen N, Horrevoets A and Lutgens E (2016) CD40 in coronary artery disease: a matter of macrophages?, Basic Research in Cardiology, 10.1007/s00395-016-0554-5, 111:4, Online publication date: 1-Jul-2016. Jin X, Liu L, Zhou Z, Ge J, Yao T and Shen C (2016) Pioglitazone alleviates inflammation in diabetic mice fed a high-fat diet via inhibiting advanced glycation end-product-induced classical macrophage activation, The FEBS Journal, 10.1111/febs.13735, 283:12, (2295-2308), Online publication date: 1-Jun-2016. Su Z, Zhang P, Yu Y, Lu H, Liu Y, Ni P, Su X, Wang D, Liu Y, Wang J, Shen H, Xu W and Xu H (2016) RETRACTED ARTICLE: HMGB1 Facilitated Macrophage Reprogramming towards a Proinflammatory M1-like Phenotype in Experimental Autoimmune Myocarditis Development, Scientific Reports, 10.1038/srep21884, 6:1, Online publication date: 20-Apr-2016. Lan G, Xie W, Li L, Zhang M, Liu D, Tan Y, Cheng H, Gong D, Huang C, Zheng X, Yin W and Tang C (2016) MicroRNA-134 actives lipoprotein lipase-mediated lipid accumulation and inflammatory response by targeting angiopoietin-like 4 in THP-1 macrophages, Biochemical and Biophysical Research Communications, 10.1016/j.bbrc.2015.10.158, 472:3, (410-417), Online publication date: 1-Apr-2016. Zhou Z, Tang Y, Jin X, Chen C, Lu Y, Liu L and Shen C (2016) Metformin Inhibits Advanced Glycation End Products-Induced Inflammatory Response in Murine Macrophages Partly through AMPK Activation and RAGE/NF κ B Pathway Suppression , Journal of Diabetes Research, 10.1155/2016/4847812, 2016, (1-10), . Lu J, Yao X, Xiu J and Hu Y (2016) MicroRNA-125b-5p attenuates lipopolysaccharide-induced monocyte chemoattractant protein-1 production by targeting inhibiting LACTB in THP-1 macrophages, Archives of Biochemistry and Biophysics, 10.1016/j.abb.2015.11.007, 590, (64-71), Online publication date: 1-Jan-2016. De Paoli F, Copin C, Vanhoutte J, Derudas B, Vinod M, Zawadzki C, Susen S, Pattou F, Haulon S, Staels B, Eeckhoute J, Chinetti-Gbaguidi G and Nagy L (2015) Transducin-like enhancer of split-1 is expressed and functional in human macrophages, FEBS Letters, 10.1002/1873-3468.12029, 590:1, (43-52), Online publication date: 1-Jan-2016. Wang J, Bai X, Song Q, Fan F, Hu Z, Cheng G and Zhang Y (2015) miR-223 Inhibits Lipid Deposition and Inflammation by Suppressing Toll-Like Receptor 4 Signaling in Macrophages, International Journal of Molecular Sciences, 10.3390/ijms161024965, 16:10, (24965-24982) Li M, Lin F, Lin Y and Peng W (2015) Extracellular polysaccharide from Bordetella species reduces high glucose-induced macrophage apoptosis via regulating interaction between caveolin-1 and TLR4, Biochemical and Biophysical Research Communications, 10.1016/j.bbrc.2015.09.125, 466:4, (748-754), Online publication date: 1-Oct-2015. Eom M, Hudkins K and Alpers C (2015) Foam cells and the pathogenesis of kidney disease, Current Opinion in Nephrology and Hypertension, 10.1097/MNH.0000000000000112, (1), Online publication date: 1-Apr-2015. Jin X, Yao T, Zhou Z, Zhu J, Zhang S, Hu W and Shen C (2015) Advanced Glycation End Products Enhance Macrophages Polarization into M1 Phenotype through Activating RAGE/NF- κ B Pathway , BioMed Research International, 10.1155/2015/732450, 2015, (1-12), . December 5, 2014Vol 115, Issue 12 Advertisement Article InformationMetrics © 2014 American Heart Association, Inc.https://doi.org/10.1161/CIRCRESAHA.114.305641PMID: 25477492 Originally publishedDecember 5, 2014 PDF download Advertisement
Referência(s)